Laboratory evaluation of molecular xenomonitoring using mosquito excreta/feces to amplify Plasmodium, Brugia, and Trypanosoma DNA by Pilotte, Nils et al.
Gates Open Research
 
Open Peer Review
Any reports and responses or comments on the
article can be found at the end of the article.
RESEARCH ARTICLE
Laboratory evaluation of molecular xenomonitoring using
mosquito excreta/feces to amplify , , and Plasmodium Brugia
  DNATrypanosoma [version 1; peer review: awaiting peer review]
Nils Pilotte ,       Darren A.N. Cook , Joseph Pryce , Michael F. Zulch ,
   Corrado Minetti , Lisa J. Reimer , Steven A. Williams1,2
Department of Biological Sciences, Smith College, Northampton, Massachusetts, 01063, USA
Molecular and Cellular Biology Program, University of Massachusetts, Amherst, Massachusetts, 01003, USA
Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA, UK
Abstract
Results from an increasing number of studies suggest thatBackground:  
mosquito excreta/feces (E/F) testing has considerable potential to serve as
a supplement for traditional molecular xenomonitoring techniques.
However, as the catalogue of possible use-cases for this methodology
expands, and the list of amenable pathogens grows, a number of
fundamental methods-based questions remain. Answering these questions
is critical to maximizing the utility of this approach and to facilitating its
successful implementation as an effective tool for molecular
xenomonitoring.
Utilizing E/F produced by mosquitoes or tsetse fliesMethods:  
experimentally exposed to  ,  , or Brugia malayi Plasmodium falciparum
, factors such as limits of detection, throughputTrypanosoma brucei brucei
of testing, adaptability to use with competent- and incompetent-vector
species, and effects of additional blood feedings post parasite-exposure
were evaluated.  Two platforms for the detection of pathogen signal
(quantitative real-time PCR and digital PCR [dPCR]) were also compared,
with strengths and weaknesses examined for each.      
Experimental results indicated that high throughput testing isResults:  
possible when evaluating mosquito E/F for the presence of either B. malayi 
or   from both competent- and incompetent-vector mosquitoP. falciparum
species.  Furthermore, following exposure to pathogen, providing
mosquitoes with a second, uninfected bloodmeal did not expand the
temporal window for E/F collection during which pathogen detection was
possible.  However, this collection window did appear longer in E/F
collected from tsetse flies following exposure to  .  Testing alsoT. b. brucei
suggested that dPCR may facilitate detection through its increased
sensitivity.  Unfortunately, logistical obstacles will likely make the
large-scale use of dPCR impractical for this purpose.
By examining many E/F testing variables, expansion of thisConclusions:  
technology to a field-ready platform has become increasingly feasible. 
However, translation of this methodology from the lab to the field will first
require the completion of field-based pilot studies aimed at assessing the
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require the completion of field-based pilot studies aimed at assessing the
efficacy of E/F screening.
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Introduction
Due largely to renewed commitments and coordinated efforts 
between local leaders, government officials, non-government 
organizations, international donors, and pharmaceutical com-
panies, tropical disease control, elimination, and eradication 
efforts are making unprecedented gains1–5. Combined approaches, 
integrating chemotherapies, vector control strategies, education 
and outreach, and improvements to infrastructure are all contrib-
uting to significant programmatic successes. These successes are 
generating lofty goals for future interventions and expanding 
belief in the possibility of elimination of some tropical vector-
borne diseases3,6–10. However, as successes mount, new challenges 
arise, including an increasingly pressing need for capable sur-
veillance tools. Following suspected transmission interruption, 
a failure of surveillance to identify and quickly react to possible 
incidences of disease recrudescence has significant potential 
to result in the forfeiture of hard-fought gains. For years, phar-
maceutical partners and non-government organizations have 
supported programmatic efforts with substantial financial 
commitments, making such gains possible11. However, insuf-
ficient oversight or inadequate follow-through may result in sub-
stantial disease rebound. Should such recrudescence occur in 
locations where transmission interruption or elimination efforts 
were previously believed to have succeeded, the remobilization 
of significant economic resources may not occur. Given these 
stakes, the need for low cost, non-invasive, high throughput sur-
veillance methods is paramount to the realization of long-term 
programmatic goals.
Despite facing many challenges, the Global Programme for 
the Elimination of Lymphatic Filariasis (GPELF) continues to 
make remarkable progress in its efforts to meet its ambitious 
targets. Through the incorporation of novel strategies, such as 
triple drug (Ivermectin, Diethylcarbamazine, and Albendazole 
(IDA)) therapy12–17, global intervention efforts are beginning to 
realize more rapid successes. These accelerated accomplishments 
are allowing a growing number of countries to aspire towards 
World Health Organization (WHO)-sanctioned certification of 
lymphatic filariasis (LF) elimination. Currently, transmission 
assessment surveys (TAS) are used as the primary tool for 
measuring the successes of programmatic interventions18,19. 
However, pilot studies are demonstrating that TAS surveys 
may not be well-suited to surveillance and monitoring in IDA 
settings, and the need to re-examine monitoring and evaluation 
strategies under triple-drug interventions has been recognized20. 
This has prompted the organization of operational research (OR) 
efforts aimed at developing an appropriate monitoring and 
evaluation strategy for triple drug stopping decisions. (Please 
see www.ntdsupport.org/cor-ntd/ntd-connector/term/lymphatic- 
filariasis for examples.) Such efforts may benefit from novel and 
innovative diagnostic screening methods. Of further concern, 
recent modeling efforts of helminth infection suggest that even 
in conventional treatment settings, the potential for recrudes-
cence of infection, particularly when systemic non-compliance 
with mass drug administration (MDA) is significant, is likely 
greater than previously believed21. Applying the findings of these 
predictive models to filarial infection, the threat of rebound 
likely extends for a period of many years past the WHO-suggested 
timeline for the completion of post-intervention TAS surveys. 
Warning signs of infection rebound, resulting from pockets 
of sustained focal transmission, are also being identified with 
increased frequency as “successful” LF elimination programs 
become further removed from the cessation of MDA22–26. 
These discrepancies between defined programmatic timelines 
and the modeled potential/empirical evidence of recrudescence 
suggest there exists a post-TAS “black box” period, during 
which infection rebound is possible but appreciable monitoring 
efforts have ceased. Accordingly, integrated, non-invasive, low 
cost, high throughput approaches to surveillance, capable of 
providing a “first alert” warning during such periods are critically 
lacking27,28.
Similar to the needs of the LF community, requirements for 
improved malarial surveillance are growing. Largely due to the 
expansion of coordinated interventions under the WHO’s Global 
Malaria Programme (GMP), examples of successful elimination 
are becoming more commonplace29–31, and many additional 
elimination efforts have been established or revitalized32–34. 
While encouraging, such successes also breed new challenges 
and raise new concerns. Recognizing the dangers associated 
with bestowing a “malaria-free status” upon a population, the 
WHO has cautioned against reallocating surveillance funding 
following programmatic achievement, advising of the need to 
retain adequate surveillance systems to detect recrudescence 
and facilitate a rapid response in the event that such rebound 
occurs35. These statements warn of the potential for compla-
cency that naturally follows success, resulting in the prioritization 
of more immediate resource needs and potentially erasing years 
of progress due to insufficient post-interruption monitoring 
activities35.
Insufficient surveillance also has the potential to threaten the 
developing momentum of human African trypanosomiasis 
(HAT) elimination efforts. With 2016, 2017, and 2018 each 
marking record lows in reported global cases of HAT36–38, 
belief in the elimination of this disease as a public health 
concern is increasing. While gains realized through intervention 
have been significant and encouraging, monitoring efforts 
have relied heavily upon human sampling, an approach that is 
commonly met with increased resistance as infection prevalence 
declines39. Further complicating matters, the causative agents 
of HAT, Trypanosoma brucei spp., are vectored by the tsetse fly. 
These flies are notoriously difficult to trap, and vector control 
strategies continue to reduce their numbers40–42. While inter-
ventions aimed at decreasing fly numbers are an increasingly 
important component of transmission reduction efforts41,43, 
declining vector populations make supplemental xenosurveillance 
strategies increasingly impractical. Accordingly, as aspirations 
for elimination grow, the importance of alternative approaches to 
surveillance will continue to increase.
The molecular testing of mosquito excreta/feces (E/F) for the 
presence of pathogens provides one approach that is a poten-
tial solution to the growing surveillance challenges plaguing 
GPELF, as well as global malaria and HAT elimination efforts. 
Previously, we described the capacity for mosquito E/F testing 
to vastly improve the throughput of surveillance for filarial 
parasites44. Similarly, we demonstrated the capacity of this 
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novel molecular xenomonitoring (MX) approach to facilitate the 
detection of the human malaria-causing parasites Plasmodium 
vivax and Plasmodium falciparum44,45, and demonstrated proof-
of-concept for the “cross-vector” detection of Trypanosoma 
brucei brucei in non-vector mosquitoes45. However, the expanded 
utility of this method will require the fine tuning of sampling 
strategies, centering upon the identification of appropriate 
target mosquito populations. We have therefore performed a 
series of proof-of-concept experiments aimed at further evaluating 
the practicality of E/F testing in preparation for field 
trials. Exposing laboratory-reared mosquitoes and tsetse flies to 
various pathogens, we have endeavored to more fully understand 
the variables impacting parasite signal detection within E/F 
collected following parasite exposure.
Methods
Insect rearing and blood feeding
Mosquitoes. Both Anopheles gambiae and Aedes aegypti 
mosquitoes were internally-sourced from laboratory colonies 
maintained at the Liverpool School of Tropical Medicine. 
Mosquitoes were reared from eggs to adults and housed in 
BugDorm-1 insect rearing cages (Megaview Science, Taiwan; 
Catalogue #DP1000) at 26–27 °C with 70–80% relative 
humidity. Experimental exposures were performed as previously 
described45. Briefly, adult female mosquitoes, aged 3–7 days, were 
sugar-starved for 18 hours prior to blood exposure in order to 
facilitate blood feeding. For experiments involving exposures 
to Brugia malayi or P. falciparum, mosquitoes were provided 
with either a standard human bloodmeal (obtained from the 
local blood bank), or a human bloodmeal spiked with a known 
concentration of parasites. Exposures to B. malayi were 
conducted using a Hemotek feeding system (Hemotek Ltd, 
Blackburn, UK; Catalogue #SP6W1-3), while P. falciparum 
exposures were performed using a glass feeder (Chemglass Life 
Sciences, Vineland, NJ; Catalogue #CG-1836). For experiments 
involving mosquito exposures to T. b. brucei, mosquitoes were 
provided with a Hemotek feeding system-supplied bloodmeal 
of defibrinated horse blood (TCS Biosciences, Buckingham, 
UK; Catalogue #HB030), with or without parasites.
Tsetse flies. Flies were reared from larvae and housed in 
internally-made cages, constructed of lengths of plastic piping 
covered at each end with netting, at 27 °C ± 2 °C with a relative 
humidity of 65–75%. Adult flies were fed on defibrinated 
horse blood, with or without parasites. Feedings occurred by 
placing blood on an aluminum tray heated to 37 °C. Fly cages 
were then placed on a silicon membrane positioned directly 
above the blood, allowing flies to feed through the membrane.
Parasites
B. malayi. Microfilaria (mf) were generously provided by 
the anit-Wolbachia Consortium, generated as part of their 
maintenance of the B. malayi lifecycle46. Harvested parasites 
were added to human blood at the appropriate concentrations to 
generate experimentally desired parasite densities as described 
below for individual applications.
P. falciparum. Red blood cells containing trophozoites (3D7 
strain) were combined with uninfected human serum to produce 
experimentally desired parasite concentrations as described below 
for individual applications.
T. b. brucei. The bloodstream form of T. b. brucei, strain AnTat 
1.1 90:1347, was used for all experimental feedings. Parasites 
were cultured in HMI-11 medium supplemented with 10% fetal 
bovine serum at 37 °C and 5% CO2. Parasite densities were 
determined microscopically using a hemocytometer.
Collection of excreta/feces
B. malayi experiments. All experiments involving B. malayi 
were performed in accordance with the previously described 
superhydrophobic cone collection method45. Briefly, sheets of 
A4 printer paper were used to create cone-shaped funnels, which 
were coated in NeverWet (Rust-Oleum, Durham, UK). Cones 
were the placed inside of mesh-covered un-waxed paper beverage 
cups, with mosquitoes housed above the cones, allowing E/F 
produced by the mosquitoes to travel down the walls of 
the cones and pool at the base of each funnel. For these 
collections, GenSaver DNA Cards (GenTegra, Pleasanton, 
CA; Catalogue #GSD4-100) were used in place of the 1.7 mL 
microcentrifuge tubes that were employed when this method 
was previously described45.
P. falciparum experiments. When performing experiments 
involving P. falciparum, E/F was again collected in accord-
ance with the previously described superhydrophobic cone 
collection method45 briefly described above. For all experiments 
involving P. falciparum, E/F samples were collected into 1.7 mL 
microcentrifuge tubes as previously described45.
T. b. brucei experiments. For all experiments involving 
T. b. brucei, flies/mosquitoes were housed in 50 mL conical 
tubes allowing for direct deposition of E/F onto the walls of the 
holding vessel. During the experimental housing of vectors, 
tubes were covered with mesh netting, and flies/mosquitoes were 
transferred to new vessels at experimentally specified time inter-
vals. While in tubes, tsetse flies were removed from tubes for 
feeding on uninfected defibrinated horse blood every second day 
as described above.
Extraction of DNA from excreta/feces
Following superhydrophobic cone collections onto GenSaver 
DNA Cards. All samples were excised from GenSaver DNA 
Cards using a standard paper punch (0.64 cm round). For each 
sample, three punches were placed into a 2.0 mL microcentri-
fuge tube and the sample was recovered using the GenSolve 
DNA Recovery Kit (GenTegra; Catalogue #GVR-113) in accord-
ance with the manufacturer’s suggested protocol. Following 
recovery, each sample was added to a MinElute column 
(Qiagen, Germantown, MD) for sample binding. Sample washes 
and DNA recovery procedures occurred utilizing the manu-
facturer’s recommendations. After recovering the eluate, the 
total volume of eluate was re-loaded onto the column a second 
time and again spun through the matrix to maximize sample 
recovery.
Following superhydrophobic cone collections into microcen-
trifuge tubes. DNA was extracted from all samples utilizing the 
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QIAamp DNA Micro Kit (Qiagen; Catalogue #56304) following 
a modified version of the manufacturer’s suggested protocol. 
Briefly, 180 μL of Buffer AL was added to each E/F sample and 
tubes were vortexed on a shaking platform for 1 hr. 20 μL of 
Proteinase K was then added, and samples were incubated at 
56 °C for 1 hr with shaking at 1,400 RPM. Following incubation, 
200 μL of Buffer AL (containing 5mM carrier RNA) was 
added to each sample, and samples were incubated at 70 °C 
for 10 min. Column binding and washing steps were then 
performed in accordance with the manufacturer’s specifications. 
Following washes, elution of DNA occurred in 50 μL of 
Buffer AE. As described above, following the elution of DNA 
in 50 μL of Buffer AE, eluate was re-loaded onto the column to 
maximize recovery.
Following collection into 50 mL conical tubes. E/F was eluted 
from tubes through the direct addition of 7.5 mL of nuclease 
free water. Following the addition of water, samples underwent 
agitation on a vortexing platform for 30 min at 56 °C to facili-
tate the complete resuspension of material. Tubes were then 
spun at 5,000 RPM for 5 min, and the supernatant was removed 
from each sample. Pelleted material was resuspended in the 
residual volume of liquid. Following recovery, each sample 
underwent DNA isolation in the same manner as described above 
for superhydrophobic cone-based collections into microcentrifuge 
tubes.
Isolation of tsetse fly midguts and preparation for DNA 
extraction
Tsetse fly midguts were prepared for DNA extraction following 
the protocol previously described by Cunningham, et al.48. Briefly, 
following dissection, midguts were placed in 60 μL of 100% 
ethanol. 70 μL of nuclease free water was then added to each 
sample and samples were centrifuged at 13,000 RPM for 15 sec. 
Following centrifugation, 100 μL of supernatant was aspirated 
from each sample, and samples underwent three sequential 
washes with 100 μL of nuclease free water to remove residual 
ethanol.
Extraction of DNA from mosquitoes and tsetse flies
In preparation for DNA isolation, 20 μL of Proteinase K, 180 μL 
of Buffer ATL and a 4.5 mm ball bearing were added to all carcass 
and midgut samples. Samples were then mechanically homog-
enized at a setting of 30.0 1/S for 5 min using a TissueLyser II 
(Qiagen). All DNA extractions were then performed using the 
DNeasy Blood and Tissue Kit (Qiagen; Catalogue #69581) 
following the extraction plate procedure. All extractions were 
conducted in accordance with the manufacturer’s suggested 
protocol.
Real-time PCR
Quantitative real-time PCR (qPCR) testing for the presence/ 
absence of B. malayi occurred using the StepOnePlus Real-Time 
PCR System (ThermoFisher Scientific, Waltham, MA) and was 
performed using primers and probe previously described for use 
with the Bm HhaI real-time PCR assay49. Cycling conditions 
consisted of an initial hold at 50 °C for 2 min, followed by a 
95 °C incubation for 10 min. These incubations were followed 
by 45 cycles of sequential denaturation and annealing/extension 
steps at 95 °C for 15 sec, and 60 °C for 1 min respectively. 
Testing for the presence of P. falciparum also occurred using 
the StepOnePlus Real-Time PCR System and employed the 
recently described Pf TR1 assay in accordance with sug-
gested reagent concentrations and cycling conditions50. Cycling 
conditions for P. falciparum detection were identical to those 
described above for B. malayi detection. All reactions for 
B. malayi and  P. falciparum detection were performed in 
25 μL total volumes with 5 μL of template. Each reaction was 
conducted using 12.5 μL of TaqPath ProAmp Master Mix 
(ThermoFisher Scientific; Catalogue #A30867) and reactions 
were allowed to proceed for 45 cycles. Depending upon the 
experiment, samples were tested in duplicate or triplicate 
reactions and mean Cq values were reported as was the number 
of positive replicates.
Testing for the presence/absence of T. b. brucei was performed 
using the Rotor-Gene Q Instrument (Qiagen) and made use of 
the previously described Tb117 assay primers at concentrations 
of 400 nM48. All reactions for the detection of T. b. brucei were 
performed in 10 μL volumes, using 5 μL of Type-it HRM PCR 
Master Mix (Qiagen; Catalogue #206542) and 4μL of DNA 
template. Cycling conditions consisted of an initial hold at 
96 °C for 5 min, followed by 35 cycles of 95 °C for 15 sec, 
60 °C for 30 sec, and 72 °C for 10 sec. As this assay makes use 
of a saturating fluorescent dye (similar to SYBR Green assay 
chemistry) a dissociation step was then performed utilizing a 
temperature gradient gradually increasing from 55 °C to 95 °C. 
All T. b. brucei testing occurred in duplicate and both mean Cq 
values and the number of positive replicates were reported.
Digital PCR
All digital PCR (dPCR) reactions were performed on the 
QuantStudio 3D Digital PCR instrument using V2 chips 
(ThermoFisher Scientific; Catalogue #A26359). Reactions were 
conducted using the same P. falciparum primer-probe pairings 
selected for qPCR with identical working concentrations. All 
reactions were prepared in 15 μL volumes, with 14.5 μL of this 
prepared reaction mix loaded onto each chip for analysis. 
Individual reaction mixes contained 7.5 μL of QuantStudio 
3D Digital PCR Master Mix v2 (ThermoFisher Scientific; 
Catalogue #A26316), the appropriate concentrations of primers 
and probe, and 5 μL of template. Cycling conditions consisted 
of two initial holds at 96 °C for 10 min and 50 °C for 30 sec. These 
holds were followed by 39 cycles of 60 °C for 2 min, 98 °C for 
30 sec, and 60 °C for 2 min. Two replicate chips were analyzed 
when testing each sample. For each iteration of samples tested, 
two no template control (NTC) chips containing nuclease-free 
water in place of template were analyzed alongside experi-
mental samples. For a given iteration, NTC results were used to 
determine positivity by setting the fluorescence threshold for the 
entire sample set at 125% of the fluorescence reading generated 
by the NTC well producing the greatest level of background. 
When visualizing QuantStudio 3D output graphically, signal-
producing wells containing true positives should be located in 
positions along the x-axis directly above the population of wells 
that failed to amplify. For this reason, as well as for consist-
ency, and for the maintenance of a conservative approach to 
positivity determination, only wells with a fluorescence unit 
values of -240 to 240 along the x-axis were analyzed.
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Limits of detection for parasite signal from pooled E/F
B. malayi. Utilizing previously published temporal collection 
windows45, infected blood exposures were conducted in order 
to evaluate the capacity to detect B. malayi signal in the E/F of 
both competent (A. aegypti) and incompetent (A. gambiae) 
vectors. To evaluate limits of detection, mosquitoes were 
exposed to either 2,000 B. malayi mf/mL, or 5,000 B. malayi 
mf/mL. For each species of mosquito, either 10 or 11 replicate 
exposures were performed and the accumulated E/F was 
collected at the 48- and 72-hour time points post-exposure. An 
additional 5 mosquitoes were provided with naïve bloodmeals 
to serve as uninfected controls, and collections from naïve 
mosquitoes occurred at the same post-exposure time points. 
All collections were performed using superhydrophobic cones 
and E/F was collected onto GenSaver DNA Cards. Following 
collection, DNA was isolated from all E/F samples and the 
resulting extracts were analyzed using qPCR.
P. falciparum. As was done to evaluate limits of detection for 
B. malayi, the capacity to detect P. falciparum signal in the 
E/F of mosquitoes exposed to varying blood concentrations 
of parasite was examined. Exposures of individually housed 
A. gambiae mosquitoes occurred at 5,000 trophozoites/μL 
(0.1% parasitemia), 500 trophozoites/μL (0.01% parasitemia), 
and 50 trophozoites/μL (0.001% parasitemia), with between nine 
and 14 mosquitoes successfully undergoing exposure at each 
experimental concentration. An additional five mosquitoes were 
provided with a parasite-naïve bloodmeal for control purposes. 
Following exposure, all mosquitoes were individually housed in 
paper cups facilitating superhydrophobic cone-based collections 
of E/F into 1.7 mL microcentrifuge tubes. At the 48-hour time 
point, and again at 72 hours post-exposure, mosquitoes were 
transferred to new cups and all deposited E/F was prepared for 
qPCR analysis. In order to investigate whether dPCR could be 
used as a means of extending detection windows, E/F samples 
also underwent analysis by dPCR.
T. b. brucei. Previous work has demonstrated the successful 
detection of T. b. brucei from the E/F produced by pools of 
10 mosquitoes following exposure to parasites45. However, 
the capacity for detection of T. b. brucei signal from the E/F of 
individual mosquitoes has not yet been evaluated. The capacity 
for tsetse fly E/F to similarly allow for T. b. brucei signal 
detection has also yet to be appraised. To investigate these 
possibilities, A. gambiae and Glossina morsitans were exposed 
to defibrinated horse blood containing either “high dose” 
(105 trypanosomes/mL) or “low dose” (103 trypanosomes/mL) 
concentrations of parasites. Following exposure for 24 hours, 
individual flies and mosquitoes were transferred into 50 mL 
conical tubes for the collection of E/F. In total, E/F samples 
from 25 flies and 25 mosquitoes exposed to each dose of 
parasite were evaluated. An additional five flies and five mos-
quitoes provided with a bloodmeal that was naïve for parasite 
were included for control purposes. Following an initial 
48-hour housing, flies/mosquitoes were transferred to new 
tubes and soiled tubes were collected for molecular analysis. 
This collection process was repeated at 96 hours post-exposure, 
again at 144 hours post-exposure, and finally at 192 hours post-
exposure. DNA was then extracted from all collected samples 
and real-time PCR analysis was performed. Following the 
192-hour time point, flies and mosquitoes were sacrificed, 
and both fly midguts and mosquito carcasses underwent DNA 
extraction and qPCR analysis.
Demonstration of high throughput detection of P. falciparum 
signal from Pooled E/F
Prior experimentation has revealed the improved throughput 
of detection for B. malayi using E/F44. To investigate if 
throughput would also improve when detecting P. falciparum, 
pools of 49 A. gambiae mosquitoes were provided with a 
parasite-naïve bloodmeal and E/F from each pool was allowed 
to collect into a single microcentrifuge tube for 72 hours 
using a hydrophobic cone. Following 72 hours, this tube was 
transferred to the collecting position beneath a new cone, 
allowing for the collection of E/F from a single mosquito 
exposed to P. falciparum at a parasitemia of 0.1%. Accumula-
tion of E/F from this single exposed mosquito continued until the 
72-hour post-exposure time point, after which the tube was 
removed for downstream DNA extraction and qPCR analysis. 
All samples were tested in triplicate, and positivity was defined 
as the occurrence of a positive result in two or more reactions 
with a Cq value ≤ 40. Ten replicate pools were prepared. 
Additionally, E/F from 10 individual mosquitoes, also exposed to 
P. falciparum at the same 0.1% parasitemia, were collected for 
comparative purposes.
Effects on parasite detection of a second blood feeding 
with pathogen-naïve blood
To evaluate whether the provision of a second bloodmeal 
following an initial infected blood exposure would facilitate 
an extended window of parasite detection, three pools of 10 
A. gambiae mosquitoes were exposed to P. falciparum-contain-
ing blood at a parasitemia of 0.01%, and an additional control 
pool, also containing 10 A. gambiae mosquitoes, was provided 
with a parasite-naïve bloodmeal. Using a superhydrophobic 
cone, E/F from each pool of mosquitoes was collected 
into a microcentrifuge tube for a 72-hour period following 
exposure. Mosquito pools were then transferred to new cones, 
and E/F was allowed to accumulate for an additional 72 hours 
into a new microcentrifuge tube. At six days post-feeding, 
mosquitoes were again transferred to new cones/tubes and a 
naïve bloodmeal was provided. Following this second blood 
exposure, an additional 72-hour collection was performed. All 
collected samples then underwent DNA extraction and triplicate 
testing by qPCR (Figure 1).
Statistical analysis
Statistical differences between groups were determined 
by means of a Student’s two-tailed t-test performed using 
GraphPad’s “t test calculator” freely available from graph-
pad.com. A p value < 0.05 was considered to be statistically 
significant (*p < 0.05, **p < 0.01, ***p < 0.001). Where 
appropriate, confidence intervals were calculated using the 
previously described E. B. Wilson method51,52 utilizing software 
freely available at http://vassarstats.net/prop1.html.
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Figure 1. Schematic of the re-exposure experiment. Following 
an initial exposure to Plasmodium falciparum-positive blood, 
excreta/feces (E/F) was collected from mosquito pools for 72 hours. 
Following this time period, E/F samples were collected for qPCR 
analysis and mosquitoes were transferred to new superhydrophobic 
cones, where they were held for an additional 72 hours. At the 
conclusion of this period, E/F samples were again collected for qPCR 
analysis and mosquitoes were provided with a second bloodmeal, 
this time naïve of parasite. Mosquitoes were then transferred to a 
third superhydrophobic cone, where excretion continued for an 
additional 72 hours. Following this final incubation period, E/F was 
again collected for qPCR analysis.
Figure 2. Detection windows for parasites in the excreta/feces (E/F) of mosquitoes following a B. malayi-containing bloodmeal. 
Individual (A) Aedes aegypti (competent vector) mosquitoes and (B) Anopheles gambiae (incompetent vector) mosquitoes were exposed 
to a Brugia malayi-containing bloodmeal at a parasitemia of either 5000 mf/mL or 2000 mf/mL. E/F was then collected from each mosquito, 
individually, in 24-hour time blocks. Collected E/F samples were then tested in duplicate qPCR reactions. Colors represent Cq values, and 
numbers in parenthesis indicate the number of positive qPCR replicates. (C) A comparison of the mean Cq values from all positive E/F 
samples produced by both mosquito species at both parasitemias. Significance, as determined by the results of unpaired t tests, is provided. 
*p < 0.05, **p < 0.01, NS = not significant.
Results
Raw qPCR and dPCR data underlying the below results are 
available as underlying data53.
Limits of detection for parasite signal from pooled E/F
B. malayi. Individual competent vector (A. aegypti) and incom-
petent vector (A. gambiae) mosquitoes were exposed to B. malayi 
at blood concentrations of 2,000 mf/mL or 5,000 mf/mL. 
E/F collection occurred at the 48- and 72-hour post-exposure 
time points. Irrespective of time point, qPCR analysis resulted 
in the detection of parasite signal from the E/F of 10 of 11 
A. aegypti mosquitoes exposed at a parasitemia of 5,000 mf/mL, 
and from 9 of 11 A. aegypti mosquitoes exposed at a parasitemia 
of 2,000 mf/mL (Figure 2A). Results for A. gambiae exposures 
were similar, with positive detection occurring in 8 of 10 pools 
produced from mosquitoes exposed at a parasitemia of 5,000 mf/mL 
and in 10 of 11 pools produced following exposure at a para-
site density of 2,000 mf/mL (Figure 2B). Consistency of 
detection across time points was greater when testing E/F 
produced by A. aegypti, occurring for six mosquitoes follow-
ing exposure at 5,000 mf/mL, and five mosquitoes following 
exposure at 2,000 mf/mL. In E/F produced by A. gambiae, 
detection across multiple time points occurred from only two 
mosquitoes and one mosquito following exposures to B. malayi 
at 5,000 mf/mL and 2,000 mf/mL respectively. Unsurprisingly, 
mean Cq values were lower, suggesting greater concentrations 
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of target DNA, in the E/F produced by mosquitoes exposed to 
higher blood concentrations of B. malayi (Figure 2C). Of note, 
a single negative control mosquito, not exposed to B. malayi, did 
give a positive signal. Contamination, resulting in amplification, 
likely occurred either during mosquito rearing or during DNA 
extraction. The use of no-template negative controls during PCR 
suggests that the contamination was unlikely to have occurred 
during the PCR.
P. falciparum. Following exposure of individual A. gambiae 
mosquitoes to P. falciparum at parasitemias of 0.1% (5000/μL), 
0.01% (500/μL), and 0.001% (50/μL), E/F was collected at the 
48-hour and 72-hour time points. As measured by qPCR, all nine 
mosquitoes exposed at 0.1% produced E/F that gave positive 
results: four samples were positive at the 48-hour time point, 
while six were positive at the 72-hour time point. Following 
exposure at 0.01% parasitemia, 13 of 14 mosquitoes produced 
E/F that gave positive qPCR results: 12 were positive at the 
48-hour time point, while only one sample was positive at the 
72-hour time point. Exposures at 0.001% parasitemia resulted in 
positive detection from the E/F produced by seven of 11 mos-
quitoes: four were positive at the 48-hour point, while three 
were positive at the 72-hour point (Figure 3A). Interestingly, 
only one mosquito produced sample that was detectable at both 
collection time points (0.1%, sample 2). This result was in 
sharp contrast with findings for B. malayi (Figure 2A, B). Taken 
together, these results may mean that deposition of parasite 
material occurs largely as the result of a solitary excretion event. 
When signal detection occurs across time points, it may be 
that this event spans collection intervals, resulting in multiple 
positive time points from an isolated excretion occurrence. 
Whether the duration of this excretion event is longer following 
a B. malayi exposure, or these findings are chance results, remains 
an open question.
Figure 3. Detection windows for parasites in the excreta/feces (E/F) of mosquitoes following a Plasmodium falciparum-containing 
bloodmeal. (A) Individual Anopheles gambiae mosquitoes were exposed to a P. falciparum-containing bloodmeal at a parasitemia of 
5000 trophozoites/mL (0.1% parasitemia), 500 trophozoites/mL (0.01% parasitemia) or 50 trophozoites/mL (0.001% parasitemia). E/F 
was then collected from each mosquito, individually, in 24 hour time blocks. Collected E/F samples were then tested in triplicate qPCR 
reactions. Colors represent Cq values, and numbers in parenthesis indicate the number of positive qPCR replicates. (B) A comparison of 
the mean Cq values from all qPCR-positive E/F samples (irrespective of time point) produced by mosquitoes at each tested parasitemia. 
Significance, as determined by the results of unpaired t tests, is provided. **p < 0.01, ***p < 0.001. (C) Testing, in duplicate dPCR 
reactions, of the same samples collected in panel A. Colors represent the number of positive sample wells per reaction, and numbers 
in parenthesis indicate the number of positive dPCR replicates. (D) A comparison of E/F sample positivity as determined by qPCR 
and dPCR results from panels A and C.
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As expected, and as seen following B. malayi exposures, Cq 
values increased with declining numbers of parasites, suggesting 
greater amounts of template in the E/F produced by mosqui-
toes exposed to higher concentrations of pathogen (Figure 3B). 
Digital PCR analysis of samples resulted in the improved 
overall sensitivity of detection, as more positive results were 
seen at the 48–72-hours time point compared to the qPCR 
results (Figure 3A, C). In total, across all parasite concentra-
tions, 17 qPCR negative samples demonstrated positivity when 
tested by dPCR, while only 1 sample which was qPCR positive 
produced a negative result by dPCR (Figure 3D).
T. b. brucei. Following exposure to T. b. brucei, E/F was 
collected from individually housed G. morsitans and A. gambiae 
at 48 hour intervals. Within 96 hours of exposure to “high dose” 
T. b. brucei (105 trypanosomes/mL), 23 of 25 individually 
housed G. morsitans had produced at least one E/F sample that 
was qPCR positive for parasite (96%). In contrast, only six of 
the 25 individual A. gambiae mosquitoes exposed to the “high 
dose” produced E/F which was qPCR positive for T. b. brucei. 
Following “low dose” exposures (103 trypanosomes/mL), six out 
of 25 tsetse flies produced parasite-positive E/F (24%) within 
96 hours of exposure, while a single mosquito out of the 25 
exposed was T. b. brucei positive by qPCR (4.0%) (Figure 4A). 
Interestingly, E/F-based T. b. brucei detection from E/F produced 
by G. morsitans readily occurred at the 192-hour time point 
following both “high dose” (70.8%) and “low dose” (20.8%) 
exposures to parasite (Table 1). In contrast, only the E/F produced 
by a single mosquito gave positive T. b. brucei qPCR detection 
at a time point later than 96 hours post-infection (4.2%), and this 
sample was derived from an individual of “low dose” exposure 
(Table 1).
Following sacrifice at the 196-hour time point, qPCR analysis 
of DNA extracted from G. morsitans midguts and A. gambiae 
carcasses was performed. Testing revealed T. b. brucei positivity 
in 15 of 20 midgut-derived samples from G. morsitans 
subjected to “high dose” exposures, and in 3 of 14 samples 
collected from “low dose” individuals. Neither “high” nor 
“low dose” mosquitoes produced a single T. b. brucei-positive 
carcass (Figure 4B).
Demonstration of high throughput detection of P. falciparum 
signal from pooled E/F
To investigate the capacity for high throughput sampling when 
testing mosquito E/F for the presence of P. falciparum by qPCR, 
Figure 4. Levels of qPCR positivity in excreta/feces (E/F) pools and exposed insects following a Trypanosoma brucei 
brucei-containing bloodmeal. (A) Twenty-five G. morsitans and 25 A. gambiae were provided with a T. b. brucei-positive bloodmeal 
at either high (105 trypanosomes/mL; red) or low (103 trypanosomes/mL; blue) parasitemias. E/F was collected from individual insects 
and tested by qPCR for T. b. brucei. Results are shown as percentages of positive E/F pools ± 95% CI. (B) Following high- or low-dose 
exposures to T. b. brucei and subsequent collection and testing of E/F (depicted in panel A), DNA was extracted from Glossia morsitans 
midguts and Anopheles gambiae carcasses. Extracts were tested for pathogen presence by qPCR and results are shown as percentages 
of exposed insects testing positive by qPCR ± 95% CI.
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comparative analysis of samples containing the pooled E/F from 
50 mosquitoes (49 unexposed and 1 P. falciparum-exposed) and 
mosquitoes individually exposed to P. falciparum was performed. 
Eight of 10 samples containing pooled E/F gave positive qPCR 
results with a mean Cq value of 31.37 for all positive samples. 
By comparison, nine of 10 control samples containing the E/F 
from individually exposed mosquitoes resulted in the detection 
of P. falciparum signal, with a mean Cq value of 28.33 for all 
positive samples (Figure 5).
Effects on parasite detection of a post-exposure second 
blood feeding with pathogen-naïve blood
Following an initial exposure to an infected bloodmeal, detec-
tion of P. falciparum signal in the E/F from all three experimental 
pools of 10 mosquitoes occurred. As expected, at the 144-hour 
post-exposure time point, signal detection was no longer 
possible. Following the provision of a second, uninfected 
bloodmeal, signal remained undetectable, indicating that such 
an exposure was not capable of extending, or re-initiating the 
post-parasite exposure collection window (Table 2).
Discussion
Proof-of-concept work has previously demonstrated the capacity 
for mosquito E/F to serve as a novel, high throughput test-
ing medium for various parasitic and viral pathogens44,45,54–58. 
However, the future utility of E/F testing will depend upon an 
ability to effectively and efficiently collect and test E/F from the 
appropriate mosquito source populations. Having previously 
described a novel methodology facilitating the high throughput 
collection of mosquito E/F45, the work described here aimed 
to identify the characteristics of such mosquito populations 
through the definition of amenable mosquito species, and the 
determination of optimal pathogen densities, and sample pool 
sizes.
Figure 5. High throughput detection of Plasmodium falciparum signal from pooled excreta/feces (E/F). Individual Anopheles gambiae 
mosquitoes were exposed to P. falciparum trophozoites at a parasitemia of 0.1%. E/F was then collected from mosquitoes, either individually, 
or following pooling with 49 additional A. gambiae mosquitoes having been exposed to a parasite-naïve bloodmeal. All E/F samples were 
then tested by qPCR, in triplicate reactions, for the presence of P. falciparum signal. Mean results from the testing of each pool are indicated. 
Significance, as determined by the results of unpaired t tests, is provided. **p < 0.01.
Table 1. Percentage of qPCR-positive excreta/feces (E/F) Pools collected from Glossina morsitans 
and Anopheles gambiae following exposure to both “high dose” and “low dose” concentrations of 
trypanosomes.
High Dose (105 trypanosomes/mL) Low Dose (103 trypanosomes/mL)
Post-Exposure 
Time Point (Hrs)
G. morsitans 
% Positive (95% CI)
A. gambiae 
% Positive (95% CI)
G. morsitans 
% Positive (95% CI)
A. gambiae 
% Positive (95% CI)
48 56.0 (35.3 – 75.0) 24.0 (11.5 – 43.4) 0.0 (0.0 – 13.3) 0.0 (0.0 – 13.3)
96 50.0 (31.4 – 68.6) 0.0 (0.0 – 13.3) 0.0 (0.0 – 13.3) 4.0 (0.7 – 19.5)
144 45.8 (27.9 – 64.9) 0.0 (0.0 – 13.8) 8.7 (2.4 – 26.8) 4.2 (0.7 – 20.3)
192 70.8 (50.8 – 85.1) 0.0 (0.0 – 13.8) 20.8 (9.2 – 40.5) 0.0 (0.0 – 13.8)
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For the detection of B. malayi, the testing of E/F from both 
competent- and incompetent-vectors consistently allowed for 
pathogen detection. As A. gambiae mosquitoes do not support 
B. malayi development, it logically follows that the ingested 
pathogens should undergo rapid expulsion from the mosquito 
in the E/F of these non-vector hosts. In contrast, as A. aegypti 
mosquitoes allow for B. malayi development, we initially hypoth-
esized that pathogen detection in competent vector E/F may 
be more difficult. However, even following the exposure of an 
efficient vector species to mf, the percentage of ingested worms 
that mature to the L3 stage remains relatively low59. Therefore, 
while possible differences in expulsion rates for parasite-derived 
material from competent and incompetent vector species 
could be anticipated, these disparities would likely be modest. 
Accordingly, when individual competent and incompetent 
vector mosquitoes were provided with a B. malayi-containing 
bloodmeal during the determination of detection limits, E/F 
produced by both A. aegypti and A. gambiae mosquitoes gave 
positive qPCR results from a high percentage of parasite-exposed 
mosquitoes, demonstrating the amenability of both populations 
to E/F-based collection and testing.
To an even greater extent than occurs during filarial infections 
of mosquitoes, the majority of parasites obtained by mosquitoes 
during a P. falciparum-containing bloodmeal are trophozoites, 
a lifecycle stage that is incapable of developing in the mosquito 
host60,61. Since trophozoites reach a developmental dead-end 
following a mosquito bloodmeal, it can be anticipated that they 
are rapidly expelled in the E/F. Likely for this reason, detection 
of P. falciparum appeared strong and consistent at both the 
5,000 and 500 trophozoite/μL concentrations. It should be noted 
that experimental exposures to P. falciparum were performed 
using exclusively trophozoites, effectively rendering bloodmeals 
non-infective. For this reason, exposures were only performed 
using A. gambiae mosquitoes. Given their limited numbers 
within the overall P. falciparum population, absence of gameto-
cytes would be unlikely to dramatically change expulsion rates 
of parasite-derived material. However, additional experiments in 
conjunction with future field-based testing will be conducted to 
conclusively evaluate this supposition.
Given the absence of developmental capacity of T. b. brucei 
within a mosquito, the limited detection of trypanosome signal 
in the E/F of exposed mosquitoes was unexpected. Since 
T. b. brucei is not believed capable of developing within the 
mosquito, expulsion would presumably be complete and rapid. 
Nonetheless, detection of T. b. brucei showed significantly 
greater promise when testing the E/F from tsetse flies, the 
pathogen’s vector, than when testing E/F shed by mosquitoes. 
Furthermore, the window for consistent T. b. brucei detection 
from fly E/F extended well past the 72-hour time point observed 
for pathogen detection from mosquitoes. However, improved 
detection in tsetse fly E/F may have simply been a result of 
increased bloodmeal volume (approximately 20 μL of blood 
per tsetse fly feeding62 vs. 2–4 μL per Anopheles bloodmeal63). 
Future work will aim to evaluate other “cross-vector” patho-
gen detection capacities to determine whether this limitation is 
unique to the T. b. brucei-mosquito pairing, or whether it is an 
inherent property of the “cross-vector” screening approach.
Previous work has demonstrated that the testing of mosquito 
E/F for the detection of B. malayi allows for a higher through-
put of screening when compared with standard mosquito- 
based approaches to molecular xenomonitoring44. As expected, 
experimental detection of P. falciparum demonstrated high 
throughput capability as well. While a direct comparison of E/F 
samples collected from pooled and un-pooled mosquitoes did 
result in a significant difference, these differences were marginal 
and the consistency of detection was similar (Figure 5). Additional 
testing, with larger replicate numbers and increased mosquito 
pool sizes should help to further elucidate the true extent of this 
increased capacity for high throughput screening.
Previous testing of E/F produced by laboratory-reared compe-
tent and incompetent mosquito species exposed to B. malayi, 
P. falciparum, or T. b. brucei has strongly suggested that the 
principal collection window for the detection of all tested 
pathogens occurs within the first 72 hours post-blood exposure45. 
Results of re-feeding experiments, during which a second, para-
site-naïve bloodmeal was provided to mosquitoes following an 
initial exposure, did not allow for an expansion of this window 
(Table 2). Taken together, these results strongly suggest that 
when testing for the presence of parasite signal, E/F derived 
from blood-fed, resting mosquitoes should be targeted as the 
preferred sample population. Recent work has suggested that 
collection window constraints may be less important when 
Table 2. Mean Cq values for P. falciparum detection in the excreta/feces 
(E/F) of pools of 10 exposed mosquitoes provided with a second, 
pathogen-naïve bloodmeal.
Sample 72 hr post 1° 
Exposure
144 hr post 1° 
Exposure
72 hr post 2° 
Exposure
Negative Control Pool Undetected Undetected Undetected
Experimental Pool #1 33.51 Undetected Undetected
Experimental Pool #2 31.02 Undetected Undetected
Experimental Pool #3 36.09 Undetected Undetected
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utilizing E/F for the monitoring of viral pathogens54,55. This broad-
ening of the collection window likely results from the ability 
of many viruses to replicate within the mosquito host. However, 
through the implementation of proper collection and trapping 
strategies, the surveillance of E/F for eukaryotic pathogens also 
becomes a viable option.
Despite the improved throughput of testing enabled by E/F, 
diagnostic sensitivity remains critical for drawing accurate 
conclusions from population surveys, and all possible means of 
maximizing sensitivity of detection should be evaluated. Accord-
ingly, we assessed the use of dPCR as a possible methodol-
ogy for improving the sensitivity of detection and for expanding 
temporal detection windows by comparing dPCR to standard 
qPCR in the evaluation of E/F samples produced by P. falciparum- 
exposed mosquitoes. While dPCR did expand the capacity for 
pathogen detection at reduced parasitemias, testing using the 
QuantStudio 3D dPCR platform is time-intensive and more costly 
than qPCR analysis. As such, analysis with the QuantStudio 
3D dPCR platform is likely not a practical option in most E/F 
testing environments. However, exploration of other digital PCR 
platforms, and/or technological improvements may facilitate its 
future use, and further exploration is warranted. 
While unlikely to replace the need for human sampling, or 
to completely eliminate the utility of more traditional MX 
approaches, E/F testing has the potential to serve as a com-
plementary tool, filling gaps and expanding the surveillance 
capabilities of monitoring efforts. In addition to its possible 
utility as an early warning “first alert” system for detecting 
recrudescence or residual pathogen in post-intervention settings, the 
utility of E/F testing could be expanded to fill other operational 
gaps. In the context of LF, the rapid clearance/sterilization of 
adult female worms occurring under IDA is leading to questions 
regarding the suitability of traditional TAS surveys20, as rapid 
pathogen clearance results in many individuals who are para-
site negative but antigen positive. MX has been suggested 
as a possible solution to such shortcomings, as pathogen 
presence in the mosquito population would provide real-time 
evidence of recrudescence or remaining infection “hotspots”. 
In conjunction with such efforts, the high throughput nature of 
E/F testing could facilitate its usefulness as a pre-screening tool, 
channeling the allocation of resources for traditional MX to 
populations of mosquitoes demonstrating E/F positivity. One 
could also envision E/F testing as a mechanism facilitating 
Culex spp. monitoring for LF in urban settings, where focal 
transmission can occur despite the passage of TAS criteria. 
The relative ease of Culex capture in passive traps, coupled 
with the high throughput nature of E/F testing, could facili-
tate the detection of residual infections, allowing for the rapid 
re-introduction of intervention and establishment of appropriately 
targeted human surveys.
In the context of other disease settings, should E/F testing 
prove useful for cross-vector monitoring, envisioning its use 
as a mapping tool for concomitant filarial infections may also 
become possible. In regions of the world at risk for severe 
adverse events due to the presence of multiple filarial patho-
gens, E/F pre-screening efforts could be employed to identify the 
presence of parasites such as Loa loa, helping officials to 
determine where appropriate precautions such as test-and-treat 
strategies would be required. Coupling the high throughput 
nature of E/F-based testing with the growing number of 
examples of E/F-derived viral surveillance possibilities54–57, the 
potential for integrated viral/parasite monitoring efforts also 
becomes easy to envision. With the capacity to facilitate resource 
sharing and maximization, such integrated efforts are worthy 
of further consideration/exploration.
Having successfully identified the characteristics of amenable 
mosquito populations and appropriate temporal windows for 
pathogen detection, the capacity for E/F testing must now be 
evaluated under field conditions. Ongoing work is aiming to 
evaluate both collection strategies and the potential for parasite 
detection in an operational setting. These studies will ultimately 
help to identify suitable use cases for E/F surveillance, facilitat-
ing deployment in appropriate situations and maximizing the 
utility of this novel vector screening approach.
Data availability
Underlying data
Open Science Framework: Laboratory evaluation of molecular 
xenomonitoring using mosquito excreta/feces to amplify 
Plasmodium, Brugia, and Trypanosoma DNA. https://doi.
org/10.17605/OSF.IO/EWRTJ53
This project contains the following underlying data:
•     Compiled results_Bm_LOD_realtime.xlsx. (Raw qPCR 
data underlying B. malayi LOD experiments)
•     Compiled results_Pf_LOD_realtime.xlsx. (Raw qPCR data 
underlying P. falciparum LOD experiments)
•     Compiled results_Pf_re-feed_realtime.xlsx. (Raw qPCR 
data underlying P. falciparum re-feed experiments)
•     Compiled results_Tbb_realtime.xlsx. (Raw qPCR data 
underlying experiments involving T. b. brucei)
•     Raw data_Pf_LOD_Digital.xlsx. (Raw dPCR data 
underlying P. falciparum LOD experiments)
Data are available under the terms of the Creative Commons 
Zero “No rights reserved” data waiver (CC0 1.0 Public domain 
dedication).
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